University Of California San Francisco

Researchers reported the first case of long-term HIV remission without the need for a bone marrow transplant.

Gitanjali Pai, MD, AAHIVS, has devised a way to shield patients from the stigma of an HIV diagnosis and encourage them to continue to seek care.

As a second-year medical student, I was fascinated by microbiology and pharmacology. In my third year of medical school, it became clear to me that I wanted to work in a field that required the use of broad clinical skills (both inpatient and outpatient) and that focused on the complex relationship between patients and their environment. During residency, I always found the ID cases most compelling and interesting, and I was frequently awestruck by the clinical acumen of ID physicians. But, mostly, it was the concept of the “magic bullet,” first described by Paul Ehrlich, the Nobel Prize-winning father of antimicrobial chemotherapy, that spoke directly to me. The clinical impact of antimicrobial therapy “snatching patients from the jaws of death,” which I frequently observed as a resident physician, made it clear to me that I wanted to be intimately involved in this seemingly miraculous process.

Thousands of Americans have taken to the streets to protest following the killing of George Floyd. The American Academy of Ophthalmology released a statement condemning the use of rubber bullets as a means of crowd dispersion.

A single 300 mg priming dose of tremelimumab in combination with durvalumab appeared safe and active among patients with advanced hepatocellular carcinoma, according to study results presented during the ASCO20 Virtual Scientific Program.

A little more than 3 years before the United States announced its first confirmed case of what would come to be called COVID-19, Anthony S. Fauci, MD, told a gathering of students and global health experts at Georgetown University there was “no doubt” that the Trump administration would face a surprise infectious disease outbreak. Fauci’s experience as director of the National Institute of Allergy and Infectious Diseases for more than 30 years told him that it was inevitable. Since 2000 alone, there had been outbreaks of West Nile virus, severe acute respiratory syndrome (SARS) and Zika virus, the 2009 H1N1 influenza pandemic and the years-long West African Ebola epidemic.

The COVID-19 pandemic has left academic institutions, government bodies and the private sector scrambling to find drugs to combat the novel coronavirus.

The American Cancer Society approved $36.1 million in funding for 79 research and training grants.

Parker Institute for Cancer Immunotherapy awarded up to $2.75 million in grant funding to six early career researchers.

Published results showed significant and similar improvements in range of motion and other outcomes among patients who received either early or delayed rehabilitation after reverse total shoulder arthroplasty.